📰 Human Pharma Communications News
Human Pharma Communications News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Pharma Communications. Real-time updates on events, politics, business and more.
June 1, 2024
/PRNewswire/ -- Boehringer Ingelheims new program to cap out-of-pocket costs at $35 per month for eligible patientsi for the companys inhalers is now...
October 26, 2022
FIBRONEER™ Phase III program initiated globally to evaluate BI 1015550, a novel investigational phosphodiesterase 4B (PDE4B) inhibitor, in idiopat...
September 5, 2022
InPedILD Phase III trial showed encouraging results for both primary endpoints. Full data were published in the European Respiratory Journal and presented at...
May 15, 2022
/PRNewswire/ -- Today, Boehringer Ingelheim announced Phase II data for BI 1015550, a novel investigational phosphodiesterase 4B (PDE4B) inhibitor, that was...
May 15, 2022
/PRNewswire/ -- Today, Boehringer Ingelheim announced Phase II data for BI 1015550, a novel investigational phosphodiesterase 4B (PDE4B) inhibitor, that was...